Latest News and Press Releases

SYDNEY, AUSTRALIA--(Marketwired - November 03, 2014) - Australian research that has produced a line of insulin producing cells that could eliminate the need for injections for Type 1 diabetics will be...

NEW YORK, NY--(Marketwired - October 29, 2014) -  Nuvilex, Inc. (OTCQB: NVLX) isn't letting the upcoming mid-term elections or the views in Washington, D.C., on medical marijuana slow down its...

SILVER SPRING, MD--(Marketwired - Nov 4, 2013) - Nuvilex, Inc. (OTCQB: NVLX), an international biotechnology company providing cell and gene therapy solutions for the treatment of diseases,...

SILVER SPRING, MD--(Marketwired - Oct 9, 2013) - Nuvilex, Inc. (OTCQB: NVLX) (Company), an international biotechnology company providing cell and gene therapy solutions for the treatment of...

NEW YORK, NY--(Marketwired - Oct 1, 2013) - When Nuvilex, Inc. (OTCQB: NVLX) announced that it had contracted Inno Biologics to generate cell clones that will be the basis of the company's future...

SAN DIEGO, CA--(Marketwired - Aug 27, 2013) - The OTC Journal, the longest running electronic newsletter focused on the small cap and microcap sectors, suggests investors consider the agenda when...

NEW YORK, NY--(Marketwired - Jul 30, 2013) - Nuvilex, Inc. (OTCQB: NVLX) became a much more valuable company in July when it closed a deal it was fully prepared to pay a great deal more money for,...

NEW YORK, NY--(Marketwired - Jul 9, 2013) - When Nuvilex, Inc. (OTCQB: NVLX) enters its pivotal Phase III clinical trial using its cell encapsulation technology combined with the anti-cancer drug...

NEW YORK, NY--(Marketwired - Jun 18, 2013) -  Nuvilex, Inc.'s (OTCQB: NVLX) subsidiary, Medical Marijuana Sciences, Inc., has already declared its focus will be on pancreatic cancer and cancers...

NEW YORK, NY--(Marketwired - Jun 6, 2013) - Nuvilex, Inc. (OTCQB: NVLX) has a technology in its cell encapsulation process that will very likely play some role in the future of oncology. How...